Corrigendum to "Low molecular weight fucoidan LF2 improves the immunosuppressive tumor microenvironment and enhances the anti-pancreatic cancer activity of oxaliplatin" [Biomed. Pharmacother. 173 (2024) 116360].
Fuente:
PubMed
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Artículo científico |
| Language: | en |
| Published: |
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
2026
|
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1868266074569441281 |
|---|---|
| author | Deng, Zhenzhen Qishan, Suo Zhang, Quanbin Wang, Jing Yue, Yang Geng, Lihua Wu, Ning |
| author_facet | Deng, Zhenzhen Qishan, Suo Zhang, Quanbin Wang, Jing Yue, Yang Geng, Lihua Wu, Ning Deng, Zhenzhen Qishan, Suo Zhang, Quanbin Wang, Jing Yue, Yang Geng, Lihua Wu, Ning |
| collection | PubMed - marine biology |
| contents | Corrigendum to "Low molecular weight fucoidan LF2 improves the immunosuppressive tumor microenvironment and enhances the anti-pancreatic cancer activity of oxaliplatin" [Biomed. Pharmacother. 173 (2024) 116360]. Deng, Zhenzhen Qishan, Suo Zhang, Quanbin Wang, Jing Yue, Yang Geng, Lihua Wu, Ning |
| format | Artículo científico |
| id | pubmed_41826225 |
| institution | PubMed |
| language | en |
| publishDate | 2026 |
| publisher | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie |
| record_format | pubmed |
| spellingShingle | Corrigendum to "Low molecular weight fucoidan LF2 improves the immunosuppressive tumor microenvironment and enhances the anti-pancreatic cancer activity of oxaliplatin" [Biomed. Pharmacother. 173 (2024) 116360]. Deng, Zhenzhen Qishan, Suo Zhang, Quanbin Wang, Jing Yue, Yang Geng, Lihua Wu, Ning Corrigendum to "Low molecular weight fucoidan LF2 improves the immunosuppressive tumor microenvironment and enhances the anti-pancreatic cancer activity of oxaliplatin" [Biomed. Pharmacother. 173 (2024) 116360]. Deng, Zhenzhen Qishan, Suo Zhang, Quanbin Wang, Jing Yue, Yang Geng, Lihua Wu, Ning |
| title | Corrigendum to "Low molecular weight fucoidan LF2 improves the immunosuppressive tumor microenvironment and enhances the anti-pancreatic cancer activity of oxaliplatin" [Biomed. Pharmacother. 173 (2024) 116360]. |
| url | https://pubmed.ncbi.nlm.nih.gov/41826225/ |